The National Post has an article on shortages in the supply of about 10-15 generic drugs.
The generic drug companies point to manufacturing and supply problems - and remember that this is a global industry, so we're often talking about off-shore supply problems - but the journalists can't help wondering if this reflects the recent changes in generic drug pricing regimes.
Can you prove your technical lead? What IBM’s verifiable quantum advantage
means for your patent strategy
-
A technical lead is worth what you can prove. Being first, or fastest, or
best matters only if the evidence behind the claim survives a hostile
reading, wh...
4 days ago
No comments:
Post a Comment